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MHC class II-expressing double-positive thy-
mocytes induce progression of CD4+ T cell
development as efficiently as cortical thymic
epithelial cells do. Because double-positive
thymocytes expressing CD1d select natural
killer T (NKT) cells, we investigatedwhether thy-
mocyte-selected CD4+ (T-CD4) T cells require
the same signaling components as NKT cells.
Using bone-marrow chimeras, we found that
the signaling molecules SAP, Fyn, and PKCq
were essential for T-CD4 T cell generation,
whereas mutations in the Ly108 receptor, inter-
leukin-15 receptor a, or the transcription factor
T-bet had a marginal effect. Furthermore, SAP
was critical for IL-4 production by T-CD4 T cells,
but the PKCq deficiency did not alter the ability
of T-CD4 T cells to produce cytokines. T-bet
was necessary to produce the maximum
amount of IFN-g for CD4+ T cells regardless of
the selection pathway. Thus, in contrast to
epithelial cell-selected CD4+ T cells, the two
distinct lineages of T cells selected by thy-
mocytes—i.e., T-CD4 and NKT cells—both
utilize the SAP-Fyn-PKCq pathway for their
development and function.
INTRODUCTION
It is well accepted that MHC class II expressed on cortical
thymic epithelial cells (cTECs) plays a critical and unique
role for positive selection of conventional CD4+ T cells,
and BM-derived hematopoietic cells cannot mediate pos-
itive selection of CD4+ T cells. However, we and others
identified an alternate pathway for CD4+ T cell develop-
ment, apathway that ismediatedbyMHCclass II-express-
ing thymocytes (Choi et al., 2005; Li et al., 2005). To distin-
guish between the twoCD4+ T cell populations, we named
themE- and T-CD4 T cells to reflect the cell typemediating
selection: epithelial cell-selected (E-CD4) and thymocyte-
selectedCD4 (T-CD4) T cells, respectively. Unlike E-CD4TImcells, which require an appropriate signal to differentiate to
effector T helper 1 (Th1) or Th2cells, T-CD4Tcells produce
both Th1 and Th2 cytokines immediately after in vivo stim-
ulation, which is very similar to natural killer T (NKT) cells
(Li et al., 2007). Surprisingly, interleukin-4 (IL-4) production
by T-CD4 T cells does not require signal transducer and
activator of transcription 6 (Stat6), which is also dispens-
able for NKT but not E-CD4 T cells in the generation of
IL-4. Moreover, mice with T-CD4 cells are protected from
the development of allergen-induced allergic airway in-
flammation. These data, together with another report
showing that mice with T-CD4 T cells are protected from
experimental autoimmune encephalomyelitis (EAE) (Park
et al., 2004), suggest that T-CD4 T cells could have an im-
portant immunoregulatory role. Although mice do not nat-
urally express MHC class II in thymocytes, a substantial
percentage of human fetal and neonatal thymocytes ex-
press MHC class II (Marinova et al., 2001; Park et al.,
1992; Thulesen et al., 1999), and several observations sup-
port the presence of two selection pathways in humans
(Godthelp et al., 2000; Klein et al., 1995; Markert et al.,
2004).
Both mainstream E-CD4 T cells and NKT cells are de-
rived from the same lymphocyte precursors and develop
through the double positive (DP) stage. Yet, the require-
ments for E-CD4 T cell and NKT cell development are
fundamentally different. NKT cells are positively selected
by CD1d on cortical DP thymocytes in the presence of
self-glycolipid ligands, whereas E-CD4 T cells develop
on self-peptide-MHC class II complexes on cTECs. Al-
though NKT cells share some development requirements
with T cells selected on cTECs, recent studies have dem-
onstrated that several signaling molecules, transcription
factors, and cytokines are specifically required for NKT
ontology at distinct differentiation stages (Matsuda and
Gapin, 2005).
SLAM-Associated Protein (SAP), encoded by the
Sh2d1a gene, is selectively required for NKT but not
E-CD4 T cell development in humans and mice (Chung
et al., 2005; Nichols et al., 2005a; Pasquier et al., 2005).
SAP binds to the specific tyrosine-based motifs within
the cytoplasmic tail of six SLAM-related receptors and
relays the SLAM-elicited signaling through the recruitment
and activation of the Src protein tyrosine kinase Fyn (Chan
et al., 2003; Latour et al., 2003; Sayos et al., 1998). Themunity 27, 763–774, November 2007 ª2007 Elsevier Inc. 763
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entially expressed in various immune cells, and all of them
(except CD244 and CD48) serve as self-ligand or homo-
philic receptors (Engel et al., 2003; Nichols et al., 2005b).
During T cell activation, SLAM-related receptors function
as costimulatory molecules, and the SLAM-SAP-Fyn
pathway enhances TCR-mediated and protein kinase Cq
(PKCq)-dependent NF-kB activation (Cannons et al.,
2004). PKCq-BCL10-NF-kB activation by Fyn has been
implicated in NKT cell generation (Schmidt-Supprian
et al., 2004; Sivakumar et al., 2003; Stanic et al., 2004). Be-
cause the SLAM-SAP-Fyn-PKCq signaling cascade plays
an important role in inducing TCR-mediated Th2 cytokine
production (Cannons et al., 2004; Marsland et al., 2004;
Wu et al., 2001), we have set out to test the role of this
pathway in T-CD4 T cell selection and expansion in the
thymus.
Because T-bet is thought to regulate terminal matura-
tion and survival of NKT cells (Townsend et al., 2004),
we examined its role in T-CD4 development. Similarly,
because the IL-15-IL-15R signaling pathway is important
for expansion and survival and functional maturation of
NKT cells, but not required for NKT cell generation
(Lodolce et al., 1998; Ohteki et al., 1997; Ranson et al.,
2003; Schluns et al., 2004), the effect of a disruption in
the IL-15Ra gene was evaluated.
The experiments in the current study are designed to
test the hypothesis that selection and progression of
T-CD4 T cells and NKT cells depend on similar signaling
pathways. We found that SAP, Fyn, and PKCq were
essential for T-CD4 T cell development, whereas T-bet,
IL-15Ra, and Ly108 had a marginal role. In addition,
T-CD4 T cells require SAP and T-bet to produce IL-4
and IFN-g, respectively.
RESULTS
Essential Role of SAP and Fyn in T-CD4 T Cell
Development
SAP is expressed in T cells, NK cells, and several other
hematopoietic cells (Ma et al., 2007), and its expression
in bone marrow (BM)-driven cells has been shown to be
necessary and sufficient tomediate NKT cell development
in both humans and mice (Chung et al., 2005; Nichols
et al., 2005a; Pasquier et al., 2005). Because both NKT
and T-CD4 T cells are developed through interactions be-
tween thymocytes, we hypothesized that SAP might also
be essential for T-CD4 T cell generation. To test this, we
utilized transgenic mice expressing the MHC class II
transactivator (CIITA) as a transgene (denoted henceforth
as Tg) (Patel et al., 2005). Because CIITA can activate the
expression of MHC class II and other molecules that par-
ticipate in MHC class II-restricted antigen presentation
(Reith et al., 2005), thymocytes in Tg mice express MHC
class II (Patel et al., 2005). Using Tg mice, we have dem-
onstrated that T-CD4 T cells can be developed efficiently
by MHC class II-expressing thymocytes (Li et al., 2005).
To examine the potential role of signaling molecules in
T-CD4 T cell development and function, we took advan-764 Immunity 27, 763–774, November 2007 ª2007 Elsevier Inctage of the fact that MHC class II-expressing (Tg) thymo-
cytes can select non-MHC-expressing thmocytes in trans
(Choi et al., 2005). To demonstrate the ability of Tg thymo-
cytes to mediate development of the other thymocytes
and to assess the coselection efficiency in the mixed
BM chimeric mice, BM from Tg and nontransgenic (WT)
micewere cotransferred into theMHCclass II Ab-deficient
hosts (Tg+WT/Abb/). The percentages of CD4 single-
positive (SP) thymocytes originated from Tg and WT BM
(5.5 ± 1.7 versus 3.9 ± 1.3) were not markedly different.
In the periphery, splenic T-CD4 cells accumulated to sim-
ilar numbers, although the percentage of lymph node (LN)
T-CD4 T cells from Tg BM was slightly higher than that
of the WT cells (Figures 1A and 1B). WT BM transferred
to Abb/ host in the absence of Tg BM generated very
few CD4+ T cells, similar to Abb/ mice (Li et al., 2005).
As we have reported previously (Patel et al., 2005), CD8+
T cells originated from Tg BM were over- and underrepre-
sented in the thymus and the periphery, respectively (Fig-
ures 1A and 1B). This change seems to be due to elevated
IL-4 in the Tg thymus because Tg mice deficient in IL-4
gene expression did not show the alteration in CD8+ T
cell development (Patel et al., 2005). Thus, T-CD4 T cells
are generated in Abb/ recipients when Tg thymocytes
are present. In all experiments, CD45 congenic markers
were used to distinguish cells derived from different BM
sources and the recipients.
We next tested the role of SAP in T-CD4 T cell develop-
ment. Unlike the WT BM, generation of SAP-deficient
T-CD4 cells in Tg+Sh2d1a//Abb/ mice was very
poor in the thymus as well as in the peripheral lymphoid
organs (Figure 1C, left group; Figure 1D, top left graph).
In the control chimeras (WT+Sh2d1a//B6), both WT
and Sh2d1a/ E-CD4 T cells were selected equally well
onMHC class II expressed on host cTECs (Figure 1C, right
group; Figure 1D, top right graph). The numbers of CD4+
T cells were consistent with these results (Table S1 in
the Supplemental Data available online). In contrast,
SAP did not influence the generation of CD8 SP cells in
the thymus, and Sh2d1a/ CD8 T cells tended to accu-
mulate at a higher percentage than the Tg counterparts
in the Abb/ hosts (Figure 1C, left group; Figure 1D, bot-
tom left graph). The percentages and the numbers of
CD8+ T cells in the thymus, the spleen, and the lymph
node were summarized in Tables S2 and S3, respectively.
In addition, we analyzed NKT cell development in
Tg+Sh2d1a//Abb/ and WT+Sh2d1a//WT chi-
mericmice. The proportion of NKT cells was greatly dimin-
ished if BM cells were from Sh2d1aP/ but not Tg or WT
BM cells (Figure 1E). These results were consistent with
the previous studies showing a critical role of SAP in NKT
cell ontology but not in the generation of E-CD4 T cells.
More importantly, SAP is essential not only for NKT but
also for T-CD4 T cell development.
Fyn and PKCq Are Essential for T-CD4 T Cell
Development
Fyn, the adaptor protein of SAP, is shown to be important
for NKT but not E-CD4 T cell development (Eberl et al.,.
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Signaling Requirements for T-CD4 T Cell GenerationFigure 1. SAP Plays a Critical Role in T-CD4 T Cell Development
(A) CIITA-expressing thymocytes can efficiently select WT CD4 T cells. Tg BM (CD45.1) were mixed with WT BM (CD45.1 and CD45.2) and cotrans-
ferred to the MHC class II-deficient Abb/ hosts (CD45.2). Thymocytes and LN and splenic cells from chimeric mice were analyzed for T cell repo-
pulation by Tg and WT BM. The numbers in the dot plots indicate the percentages of gated CD4+ and CD8+ T cells derived from each BM type. Data
are representative of five mice.
(B) Percentages of CD4+ (top graph) and CD8+ T cells (bottom graph) in Tg+WT/Abb/ chimeric mice. Data are shown as mean ± standard
deviation (SD) from five mice. * and ** indicate p < 0.05 and p < 0.01, respectively.
(C) SAP is necessary for T-CD4 T cell selection. Tg (CD45.1/2) and Sh2d1a/ (CD45.2) BM were cotransferred to Abb/ (CD45.1) recipients (left
group). As a control, WT (CD45.1 and CD45.2) and Sh2d1a/ (CD45.2) BM were used to reconstitute B6 (CD45.1) hosts (right group). CD4+ and
CD8+ T cell populations in thymi, LN, and spleens by cells derived from the indicated BM source were shown. The numbers in the dot plots are
the percentages of gated CD4 and CD8 cells derived from each BM type.
(D) Percentages of CD4+ (top panels) and CD8+ (bottom panels) T cells in Tg+Sh2d1a//Abb/ (right groups) and WT+Sh2d1a//WT (left
groups) chimeric mice. Data are shown as mean ± SD from four Tg+Sh2d1a//Abb/ mice and two WT+Sh2d1a//WT mice.
(E) Percentage of thymic NK1.1+TCRb+ NKT cells from different BM in Tg+Sh2d1a//Abb/ (left two panels) and WT+Sh2d1a//B6 chimeras
(right two panels). Numbers indicate the percentages of NKT cells among total thymocytes.Immunity 27, 763–774, November 2007 ª2007 Elsevier Inc. 765
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Signaling Requirements for T-CD4 T Cell GenerationFigure 2. Important Role of Fyn and PKCq in T-CD4 T Cell Selection
(A) CD4 and CD8 cell profiles in thymocytes, LN, and splenic cells from Tg+Fyn//Abb/ (left group) and WT+Fyn//B6 (right group). The
numbers in the dot plots show the percentages of gated CD4 and CD8 SP thymocytes.
(B) Percentage of CD4 SP thymocytes and LN and splenic CD4 T cells in Tg+Fyn//Abb/ (left group) and WT+Fyn//B6 chimeras (right
proup). Data are shown as mean ± SD from three and four mice, respectively.
(C) Percentage of NK1.1+TCRb+ NKT cells in Tg+Fyn//Abb/ (left group) and WT+Fyn//B6 chimeras (right proup). Numbers indicate the
percentages of NKT cells among total thymocytes.
(D) CD4 and CD8 profiles of thymocytes, LN, and splenic cells from Tg+Pkcq//Abb/ (left group) and WT+Pkcq//B6 (right group). The
numbers in the dot plots show the percentages of gated CD4 and CD8 SP thymocytes.
(E) Percentage of CD4 SP thymocytes, CD4 T cells in LN, and spleen from Tg+Pkcq//Abb/ (left group) and WT+Pkcq//WT (right group)
chimeric mice. Data are shown as mean ± SD from four and three mice, respectively.
(F) A partial defect in Pkcq/ NKT cell generation. The number in the dot plots is the percentage of thymic NK1.1+TCRb+ NKT cells in Tg+Pkcq//
Abb/ (left two panels) and WT+Pkcq//B6 chimeras (right two panels).1999; Gadue et al., 1999). Because the deficiency of SAP
dramatically reduced the T-CD4 T cell compartment, it is
possible that Fyn is also necessary for T-CD4 T cell gener-
ation. In addition, TCR engagement activates several PKC
isoforms that transduce signals to downstream events.
Among them, PKCq is selectively recruited to the immuno-
logical synapse upon TCR stimulation. Furthermore, this
recruitment is enhanced by coactivation of TCR and
SLAM (Cannons et al., 2004). Although PKCq plays an
essential role in T cell activation and survival (Cannons
et al., 2004; Coudronniere et al., 2000; Manicassamy766 Immunity 27, 763–774, November 2007 ª2007 Elsevier Incet al., 2006), it is dispensable for E-CD4 T cell develop-
ment. However, a recent study revealed a critical role of
PKCq in the generation of functional NKT cells (Stanic
et al., 2004). Therefore, we investigated the role of Fyn
and PKCq in T-CD4 T cell development.
We constructed Tg+Fyn//Abb/ andWT+Fyn//
WT chimeric mice and compared the development of
E-CD4 T cells, T-CD4 T cells, and NKT cells. Similar to
SAP, the deficiency in Fyn also diminished T- but not
E-CD4 T cell development (Figures 2A and 2B). In agree-
ment with the published studies, Fyn-deficient BM cells.
Immunity
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BM (Figure 2C). Likewise, in Tg+Pkcq//Abb/ mice,
Tg T-CD4 T cells were efficiently generated, but reconsti-
tuted Pkcq/ T-CD4 T cells were significantly reduced
(Figures 2D and 2E, left group). In contrast, the thymic gen-
eration of E-CD4 T cells was not impaired in the absence of
PKCq in comparison to the WT E-CD4 T cells shown in
WT+Pkcq//WTchimericmice (Figures 2D and 2E, right
group). However, there were fewer Pkcq/ E-CD4 T cells
than WT (p < 0.05) in LN and spleens of WT+Pkcq//
WT chimeric mice, suggesting that PKCq plays a role in
the peripheral homeostasis of E-CD4 T cells (Figures 2D
and 2E, right group). Thymic Pkcq/ NKT cells were
greatly reduced in both kinds of chimeric mice
(Figure 2F). Taken together, both Fyn and PKCq, which
function downstream of SAP, govern T-CD4 T cell as well
as NKT cell development.
Minimal Role of Ly108, T-bet, and IL-15Ra
in T-CD4 T Cell Ontology
The SLAM-related surface receptors recruit SAP, and sev-
eral family members, including CD84, CD150, CD229, and
Ly108, are all expressed on DP thymoyctes (Ma et al.,
2007). Therefore, it is possible that they participate in the
positive selection of T-CD4 T cells as well as NKT cells.
The deficiency of CD229 does not cause the impairment
of NKT cell development (Graham et al., 2006). However,
the role of Ly108 has not been demonstrated in either NKT
or CD4 T cell generation. To address this, we cotrans-
ferred Tg and Ly108-deficient (Slamf6/) BM into Abb/
hosts, and the chimeras were examined.We found a lower
representation of Slamf6/ T-CD4 T cells than Tg T-CD4,
but the differences were not significant (Figure 3A and Fig-
ure S1A, left group). In addition, Ly108 was not required
for E-CD4 development (Figure 3A and Figure S1A, right
group). Similarly, NKT cells were present in the absence
of Ly108, although the NKT cell population was slightly
reduced (Figure 3B). Thus, lack of Ly108 did not greatly
affect the development of NKTor T-CD4T cells, whichwas
in contrast to the phenotype caused by the SAP defi-
ciency. It is, however, likely that SAP controls cooperating
signals initiated by several of the SLAM-family receptors
(Engel et al., 2003; Graham et al., 2006; Howie et al.,
2005), which are requisite for T-CD4 cell development.
Using a similar scheme, we investigated the role of T-
bet in T-CD4 T cell development. T-bet regulates terminal
differentiation of NKT cells, and its deficiency results in
only a small number of immature NKT cells. If the matura-
tion programs between NKT cells and T-CD4 T cells are
similar, T-betmay play a similar role in T-CD4 cell develop-
ment. The results shown in Figure 3C indicated otherwise.
The absence of T-bet did not significantly affect thymic
development or peripheral accumulation of T-CD4 as
well as E-CD4 T cells, although in lymph nodes, Tbx21/
T-CD4 T cells were slightly decreased compared to Tg
T-CD4 T cells (Figure S1B). As expected from the pub-
lished results, Tbx21/ NKT cells were greatly under-
represented, compared to the Tg or WT counterparts
(Figure 3D).ImIL-15 through its receptor IL-15R plays a critical role in
the proliferation and expansion of mature NKT cells and
CD8 T cells that constitutively express the IL-2 and
IL-15Rb (CD122) chain. When we tested the importance
of this signaling pathway, the absence of IL-15Ra had
a marginal effect on development of T- or E-CD4 T cells
(Figure 3E and Figure S1C). Consistent with these data,
T-CD4 T cells did not express a measurable amount of
CD122, whereas a substantial proportion of NKT cells ex-
pressed CD122 (Figure S2). However, maximum NKT cell
generation seemed to require IL-15Ra because Il15ra/
NKT cells were decreased in the chimeric mice in compar-
ison to their Tg or WT controls (Figure 3F). Our results
indicate that IL-15Ra is dispensable for both T- and
E-CD4 T cell generation.
Regulation of the Cytokine Production Potential
of T-CD4 T Cells
Our data revealed that T-CD4 T cells did not completely
overlap with NKT cells or E-CD4 T cells in their develop-
mental requirements. Next, we investigated whether the
effector function of T-CD4 T cells is altered by the defi-
ciency of those signalingmolecules. Although the absence
of signalingmolecules affected T-CD4 T cell development,
the residual population of CD4+ T cells in the periphery
was detectable and hence was used to assess their cyto-
kine production potential. The key feature of T-CD4 T cell
effector function is the immediate secretion of cytokines.
Similar to NKT cells, T-CD4 cells produce both IFN-g
and IL-4 shortly after TCR stimulation without being
skewed to either Th1 or Th2 lineage (Li et al., 2007). In con-
trast, E-CD4 T cells express little cytokines under the
same condition.
We have shown that cytokine-producing T-CD4 T cells
exhibit the effector or memory phenotype (Li et al., 2007)
and that the majority of peripheral T-CD4 T cells are
CD44hi (Li et al., 2005). The deficiency of the above-stud-
ied signaling molecules had no apparent effect on the
CD44 phenotype of either E- or T-CD4 T cells in the mixed
BM chimeric mice (Figures S3A and S3B). To characterize
the cytokine production, we stimulated splenic CD4+ T
cells from the mixed BM chimeras shown in Figures 1–3
for 5 hr in the absence of exogenous cytokines. Cells
were then stained with the CD45.1, CD45.2, CD4, and
NK1.1 antibodies followed by intracellular cytokine stain-
ing (ICS) to measure IFN-g and IL-4 production in
NK1.1 CD4+ T cells.
We first examined the role of SAP by using CD4 T cells
from Tg+Sh2d1a//Abb/ and WT+Sh2d1a//
WT mice. Although the number of Sh2d1a/ T-CD4 T
cells in the periphery was dramatically reduced in these
chimeras, the residual Sh2d1a/ T-CD4 T cells were
able to produce both IFN-g and IL-4 cytokines shortly af-
ter activation (Figure 4A, compare Tg versus Sh2d1a/
T-CD4 cells in the left chimera). The proportions of
IFN-g+ cells were comparable between Sh2d1a+/+ (Tg) and
Sh2d1a/ (KO) T-CD4 T cells, whereas percentages of
IL-4+ cells were decreased in the absence of SAP. Nev-
ertheless, E-CD4 T cells showed little IL-4 expressionmunity 27, 763–774, November 2007 ª2007 Elsevier Inc. 767
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Signaling Requirements for T-CD4 T Cell GenerationFigure 3. T-CD4 T Cell Generation in the Absence of Ly108, T-bet or IL-15Ra
(A) CD4 andCD8 profiles of thymocytes, LN, and splenic cells from Tg+Slamf6//Abb/ (left group) and ofWT+Slamf6//B6 (right group) mice.
The numbers in the dot plots show the percentages of gated CD4 and CD8 T cells. The data shown here are one of three chimeras.
(B) A minor defect in Slamf6/ NKT cell generation. The number in the dot plots is the percentage of thymic NK1.1+TCRb+ NKT cells in
Tg+Slamf6//Abb/ (left two panels) andWT+Slamf6//B6 chimeras (right two panels). Numbers indicate the percentages of NKT cells among
total thymocytes.
(C) CD4 and CD8 cell populations in thymocytes, LN, and splenic cells from Tg+Tbx21 //Abb/ (left panels) and of WT+Tbx21//B6 (right
panels) mice. The numbers in the dot plots show the percentages of gated CD4 and CD8 T cells. The data shown here are one of three chimeras.
(D) The percentage of thymic NK1.1+TCRb+ NKT cells in Tg+Tbx21//Abb/ (left two panels) andWT+Tbx21//B6 chimeras (right two panels).
Numbers indicate the percentages of NKT cells among total thymocytes.
(E) CD4 and CD8 profiles from indicated organs in Tg+Il15ra//Abb/ and WT+Il15ra//B6 mice. The numbers in the dot plots show the
percentages of gated CD4 and CD8 T cells driven from each BM source. The data shown here are one of three or four chimeras.
(F) The percentage of thymic NK1.1+TCRb+ NKT cells in Tg+Il15ra//Abb/ (left two panels) and WT+Il15ra//B6 chimeras (right two panels).
Il15ra/ BM had a reduction of the NKT cell population in the mixed BM chimeric mice. Data are representative of four individual chimeras. Numbers
indicate the percentages of NKT cells among total thymocytes.and small numbers of IFN-g+ cells regardless of the SAP
status (Figure 4A, right group). Similarly, Ly108-deficient
T-CD4 T cells produced both IFN-g and IL-4 at a compa-
rable amount to that of Ly108-sufficient cells (Figure 2B).
Therefore, SAP and Ly108 are not essential for T-CD4 T768 Immunity 27, 763–774, November 2007 ª2007 Elsevier Inccells to produce cytokines, but SAP appears to be re-
quired for optimal production of IL-4 by T-CD4 T cells.
The downstream T cell signaling events that are impor-
tant for IL-4 production and also known to be affected by
SAP deficiency include PKCq recruitment to lipid rafts,.
Immunity
Signaling Requirements for T-CD4 T Cell Generationdownstream IkBadegradation, andNF-kB1 nuclear trans-
location (Cannons et al., 2004). However, PKCq deficiency
had little effect on IL-4 or IFN-g production by T-CD4 T
cells (Figure 4C, left group), which indicates other signal-
Figure 4. Effect of Signaling Molecules on the Cytokine
Production Potential of T-CD4 T Cells
Splenic cells from the same chimeric mice described in Figures 1–3
were stimulated for 5 hr as described in the Experimental Procedures
in the absence of exogenous cytokines. IFN-g (top row) and IL-4 (bot-
tom row) production by CD4+ T cells from theSh2d1a/ (A), Slamf6/
(B), Pkcq/ (C), Tbx21/ (D), and Il15ra/ (E) chimeric mice was
assessed by ICS. Results were representative of at least three mice
per group.Iming pathways might compensate PKCq deficiency in
mediating SAP signal transduction to the IL-4 gene.
T-bet is a critical transcription factor for IFN-g gene
expression in E-CD4 T cells (Szabo et al., 2000). Similar
toE-CD4Tcells (Figure4D, right group), therewasa reduc-
tion in IFN-g+ cells that were from the Tbx21/ origin in
Tg+Tbx21//Abb/ chimeras (Figure 4D, left group).
However, when we compared the IFN-g production be-
tweenT-betdeficientE-andT-CD4Tcells, the twoshowed
a difference. As reported, E-CD4 T cells generated no de-
tectable IFN-g-producing cells without T-bet, whereas
Tbx21/ T-CD4 T cells expressed IFN-g, albeit at a low
amount. Therefore, T-bet is important for IFN-g production
by both E- and T-CD4 T cells but less critical for T-CD4 T
cells. Finally, we analyzed the cytokine production poten-
tial by Il15ra/ T-CD4 T cells. IFN-g production was
reduced slightly in both Il15ra/ T- and E-CD4 T cells,
whereas the ability to produce IL-4 by T-CD4 T cells was
not affected by IL-15Ra deficiency (Figure 4E). Thus, the
cytokine production potential of T-CD4 T cells is differen-
tially regulated by signaling molecules.
The Role of the Signaling Molecules
in Th1 and Th2 Differentiation
The results shown in Figure 4 demonstrated the differential
potential of CD4+ T cells to produce cytokines in the ab-
sence of exogenous cytokines. We next examined Th1
or Th2 effector cells to ascertain the function of signaling
molecules during Th cell differentiation of T-CD4 T cells.
Among several signaling molecules, we chose to examine
SAP, PKCq, and T-bet, which are known to be critical for
Th cell differentiation. Splenic CD4+ T cells from the mixed
BM chimeric mice that generate either E- or T-CD4 T cells
were differentiated under Th1- and Th2-inducing condi-
tions for 6 days as described in the Experimental Proce-
dures, and their cytokine production profiles were quanti-
fied by ICS.
On the basis of the published reports (Cannons et al.,
2004; Wu et al., 2001), we expected that Sh2d1a/
E-CD4 T cells would respond normally to the Th2-skewing
conditions and express IL-4. Indeed, differentiation of
Sh2d1aP/ E-CD4 T cells to either Th1 or Th2 cells was
not affected (Figure 5A, right group). One of the character-
istics of T-CD4 T cells is their ability to produce Th2 cyto-
kines including IL-4 even under the Th1-skewing condition
(Li et al., 2007; Patel et al., 2005). In fact, Th1 cells gener-
ated from SAP-sufficient T-CD4 T cells produced IL-4
(Figure 5A, left group). In contrast, T-CD4 T cells lacking
SAP produced a reduced amount of IL-4 under Th1 as
well as Th2 conditions (Figure 5A). Nevertheless,
Sh2d1a/ Th1 cells produced IL-4 under the Th1 skewing
conditions if they were selected on thymocytes but not on
epithelial cells (compare KO cells between the two
chimeras).
PKCqhasbeenshown tobe important for IL-4production
byE-CD4Tcells (Marsland et al., 2004).Whenweassessed
IL-4 production, E-CD4 T cells were not able to make the
maximum amount of IL-4 without PKCq (Figure 5B, right
group). However, PKCq seems to be dispensable formunity 27, 763–774, November 2007 ª2007 Elsevier Inc. 769
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an equivalent amount of IL-4 under either the Th1- or the
Th2-skewing condition (Figure 5B, left group).
T-bet is critical for Th1 differentiation of E-CD4 T cells
(Szabo et al., 2000), and Th1 cells lacking T-bet barely
expressed IFN-g when they were selected on TEC
(Figure 5C, right group). When T-CD4 T cells were exam-
ined, Tbx21/ Th1 cells could make IFN-g but much
less than T-bet-sufficient T-CD4 T cells (Figure 5C, left
group). Therefore, IFN-g production is compromised in
both E- and T-CD4 T cells if T-bet is not expressed. Over-
Figure 5. Cytokine Production by Th1- or Th2-Differentiated
T-CD4 T Cells Deficient in Signaling Molecules
The samechimericmice described in Figures 1–3were used to prepare
splenic CD4+ T cells. Cells were cultured under the Th1- or Th2-skew-
ing condition, restimulated for 5 hr, and analyzed for IFN-gand IL-4pro-
duction as described in the Experimental Procedures. Cytokine pro-
duction by T-CD4 T cells deficient in SAP (A), PKCq (B), and T-bet (C)
is shown. Results were representative of at least two mice per group.770 Immunity 27, 763–774, November 2007 ª2007 Elsevier Inall, the molecular mechanisms responsible for the produc-
tion of Th1 or Th2 cytokines are not identical between
E- and T-CD4 T cells.
DISCUSSION
T-CD4 T cells are positively selected by MHC class II-ex-
pressing thymocytes, similar to NKT cells that are selected
by CD1d-expressing thymocytes. In this study, we inves-
tigated signaling requirements for the development and
effector function of T-CD4 T cells. By analyzing several
molecules known to be associated with NKT cell ontology,
we showed that SAP, which is crucial for the NKT cell de-
velopment in both humans and mice, is also required for
the generation of T-CD4 T cells. Fyn and PKCq were
also involved in the development of both lineages. We ob-
served that T-CD4 T cell development was more severely
impaired by the deficiency of SAP than Fyn. SAP is known
to regulate CD4+ T cell-mediated help for humoral immu-
nity through a Fyn-independent pathway (Cannons et al.,
2006; McCausland et al., 2007). Perhaps SAP could also
activate Fyn-independent pathways that facilitate T-CD4
T cell development. Nonetheless, the SAP-Fyn-PKCq sig-
naling pathway plays an important role in the development
of both thymocyte-selected NKT cells and T-CD4 T cells.
In contrast, T-bet and IL-15Ra were dispensable for E- or
T-CD4 T cell development. Therefore, our data indicate
that development of T-CD4 T cells and NKT cells share
the requirement for some of the samemolecules, presum-
ably as a result of the common selection pathway by thy-
mocytes. Yet the two distinct lineages of T cells seem to
diverge at a certain point during their development and
then require different sets of signaling molecules for fur-
ther maturation.
The SLAM-SAP-Fyn-PKCq signaling pathway is consid-
ered to be specific for NKT cell generation. However, our
current study implies that the same cascade is important
for thymocyte-mediated CD4+ T cell development. Posi-
tive selection of NKT and T-CD4 T cells requires the
engagement of their TCR with the corresponding CD1d
and MHC class II complexes on selecting thymocytes
through homotypic T-T interactions. In contrast, E-CD4
T cell development is mediated by heterotypic cellular
interactions between developing thymocytes and cTECs.
Consequently, differences in the surface receptors and/or
cytokines expressed by cTECs and thymocytes are likely
to determine the activation of distinct signaling pathways
that contribute to the development and function of differ-
ent T cell subsets and NKT cells. In this regard, the costi-
mulatory SLAM-related family molecules expressed on
thymocytes but not on cTECs could play an essential
role in thymocyte-mediated positive selection but have
a minimal effect on TEC-selected T cells. It is well estab-
lished that SLAM-initiated signals are relayed by the
SH2-domain-containing adaptor protein SAP to the Fyn
kinase. Activated Fyn subsequently can enhance TCR-
mediated PKCq-dependent activation of NF-kB activity.
Our study showed that SAP, Fyn, and PKCq, critical for
NKT cell ontology, are three of the important molecularc.
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M3-restricted CD8+ T cells that are selected on nonclassic
MHC class Ib-expressing hematopoietic cells (Urdahl
et al., 2002) may also depend on the same signaling com-
ponents.
Ly108, a member of the family of SLAM-related recep-
tors, had a modest role in both NKT and T-CD4 T cell
development. Because several SLAM-related receptors
are expressed on thymocytes, it is conceivable that there
may be a redundant role in NKT and T-CD4 cell develop-
ment among these receptors. Indeed, mice with the defi-
ciency in individual SLAM members such as CD229 do
not show a defect in NKT cell generation (Graham et al.,
2006). In an accompanying manuscript (Griewank et al.,
2007, [this issue of Immunity]), however, homotypic self-
interactions of both CD150 (SLAM) and Ly108 on thymo-
cytes are shown to provide essential costimulatory signals
to TCR signaling to drive NKT cell differentiation. In
addition, a recent report also linked NKT cell defects in
NOD mice to the CD150 and Ly108 loci (Jordan et al.,
2007). Whether the same homotypic signals play a role
during T-CD4 T cell development needs a further investi-
gation.
NKT cell proliferation and homeostasis highly depend
on IL-15 signaling (Matsuda et al., 2002; Ranson et al.,
2003). Therefore, mice deficient in IL-15, IL-15Ra, and
common b chain of IL-2R and IL-15R have reduced num-
bers of NKT cells (Kennedy et al., 2000; Lodolce et al.,
1998; Ohteki et al., 1997; Ranson et al., 2003; Schluns
et al., 2004). Presentation of IL-15 in trans to bystander
Il15ra/ cells can support NKT cell development (Schluns
et al., 2004). However, as we have shown here, IL-15Ra
deficiency seems to affect NKT cell development. It is
not clear what the mechanisms behind the reduction of
NKT cells are. Nevertheless, signaling mediated by the
IL-15Ra chain is not critical for T-CD4 development. Given
that the majority of resting T-CD4 T cells do not express
CD122, the nonessential role of IL-15Ra in T-CD4 genera-
tion may not be surprising. Similarly, the reason why T-bet
is not required for T-CD4 T cell development could also be
due to lack of CD122 expression on those cells.
We have reported the increase and the decrease of
CD8+ T cells in the thymus and the periphery of Tg mice,
respectively, which are influenced by IL-4 production of
T-CD4 T cells (Patel et al., 2005). Our observations are in
agreement with studies showing IL-4 transgenic mice
with a similar pattern of CD8+ T cell compartments (Lewis
et al., 1991; Tepper et al., 1990). In several mixed BM
chimeras presented here, we also observed differential
reconstitutions of CD8+ T cells originated from Tg BM. In
addition, cotransferred BM cells deficient in each individ-
ual signaling molecule yielded a varying degree of thymic
and peripheral CD8 T cells in the chimeras. One explana-
tion could be that the amount of IL-4 in the thymus varied
because of the differential contributions made by the two
populations of thymocytes, which could potentially affect
the accumulation of CD8 SP thymocytes.
Besides the role in NKT cell development, the SLAM
pathway also regulates Th2 cytokine production. In partic-Iular, SAP, Fyn, and PKCq have been shown to affect TCR-
mediated IL-4 production in E-CD4 T cells (Cannons et al.,
2004; Graham et al., 2006; Howie et al., 2005; Marsland
et al., 2004; Wu et al., 2001). The relative importance of
this pathway in Th2 differentiation of T-CD4 T cells is not
the same as we demonstrated here. We showed that
T-CD4 T cells lacking SAP but not PKCq have a defect
in IL-4 production under Th2-skewing conditions, which
is in contrast to the role of SAP or PKCq in E-CD4 T cells.
Therefore, CD4+ T cells require a different set of signaling
molecules for their development as well as function de-
pending on the selection pathway in the thymus. Although
molecular mechanisms governing the differences in shap-
ing the effector function between E- and T-CD4 T cells are
not yet clear, T-T interaction seems to be responsible for
chromatin remodeling of the IL-4 locus in the absence of
Th1 or Th2 differentiation signals (Li et al., 2007). We
have demonstrated that histone acetylation of the IL-4 lo-
cus in CD4 SP and naive CD4+ T cells is increased when
they are selected by thymocytes (Li et al., 2007). Perhaps
signals from TCR together with the SLAM-SAP-Fyn path-
way set the intracellular environment that facilitates the
activation and maintenance of IL-4 gene transcription. If
so, Stat6 would have no role in Th2 cytokine production
in T-CD4 T cells or NKT cells. Moreover, when CD4+ T
cells are developed on cTECs, they may not receive the
SLAM-SAP-Fyn-mediated signal necessary to enhance
the accessibility of transcriptional machinery to the IL-4
locus. These CD4+ T cells would require Th2-inducing
factors, such as IL-4 and Stat6, to differentiate to IL-4-pro-
ducing effector cells. Further investigations are warranted
to have a better understanding of how the IL-4 locus is
regulated differently in developing T-CD4 T cells upon
receiving a signal from another thymocyte.
The clinical significance of SAP has been illustrated in
the inherited immunodeficiency X-linked lymphoprolifera-
tive syndrome (XLP). Many of XLP patients carry muta-
tions in the SH2D1A locus that encodes SAP. They suffer
from dysfunctional immune responses to the Epstein-Barr
virus (EBV) infection (the uncontrolled expansion of B cells
and other leukocytes, the production of inflammatory
cytokines, hypogammaglobulinemia, and lymphomas)
(Coffey et al., 1998; Nichols et al., 1998; Sayos et al.,
1998). The pathogenesis has been linked to defective
cell-mediated and humoral immunity to EBV infection
(Ma et al., 2007). Given the multiple roles of NKT cells, the
clinical manifestation in these patients could be primarily
attributed to NKT cell deficiency. However, our study pre-
sented here suggests that XLP patients likely have the
impairment in development and function of T-CD4 T cells
as well. If so, defects in both NKT and T-CD4 T cells could
contribute to the compound immune dysfunction in XLP
patients.
EXPERIMENTAL PROCEDURES
Mice
Mice carrying the human type III CIITA transgene (Tg) were described
previously (Patel et al., 2005). Tg mice were bred to carry both themmunity 27, 763–774, November 2007 ª2007 Elsevier Inc. 771
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Signaling Requirements for T-CD4 T Cell GenerationCD45.1 and CD45.2 congenic markers. Non-Tg littermates from het-
erozygous Tg breeding were used as wild-type (WT) controls. T-bet-
deficient (Tbx21/) mice on the B6 background were obtained from
the Jackson Laboratory (Bar Harbor, Maine). Sh2d1a/, Fyn/,
Pkcq/, and Il15ra/ mice on the B6 background were described
previously (Lodolce et al., 1998; Sun et al., 2000; Wu et al., 2001).
Slamf6/ mice were generated by the targeting of exon 2 and 3 in
Bruce 4 (C57BL6) stem cells (N.W. and C.T., unpublished data).
CD45.1+ C57BL/6.SJL (B6) mice and the MHC class II Ab-deficient
mice on the C57BL/6 or C57BL/6.SJL background (Abb/) carrying
the CD45.2 and CD45.1 congenic marker, respectively, were pur-
chased from Taconic (Germantown, New York). All mice were housed
in the animal facility at the Indiana University School of Medicine
(IUSM) or The University of Michigan Medical School under specific
pathogen-free (SPF) conditions and used at 6–12 weeks of age. All
animal experiments were performed under protocols approved by the
institutions.
Bone-Marrow Chimeric Mice
For bone-marrow-transfer experiments, the recipient B6 or Abb/
mice were lethally irradiated with 950 rads 24 hr before receiving BM
transfers. Total BM cells were harvested from the femurs and tibias
of donor mice (2–3 months of age) and depleted of mature T cells, B
cells, and MHC class II-positive lymphocytes by using a cocktail of
antibodies containing anti-CD4 (RL172), anti-CD8 (TIB105, TIB210),
anti-CD19 (1D3), and anti-MHC class II (M5/114), followed by comple-
ment-mediated lysis. T-depleted BM cells from two different types of
donor mice were mixed at a ratio of 1:1, and each recipient mouse
received 2–5 3 105 cells in 500 ml of 13 PBS via tail vein injection.
All BM chimeraswere reconstituted for at least 8weeks before analysis
of T and NKT cell development and function.
Flow Cytometry
All antibodies used for flow cytometry were purchased from BD Phar-
Mingen (San Diego, California). Cells were preincubated with the anti-
FcgR mAb 2.4G2 to block nonspecific antibody binding before they
were stained with the following FITC-, PE-, PerCP-, CyChrome-,
APC-, or biotin-conjugated antibodies: TCRb (H57), CD4 (L3T4), CD8
(53-6.7), NK1.1 (PK136), CD45.1 (A20), CD45.2 (104), anti-IL-4
(11B11), and anti-IFN-g (XMG1.2). Flourochrome-conjugated strepta-
vidin was used to visualize staining by biotinylated primary antibodies.
Events were acquired on a FACSCalibur, LSRII, or FACSCanto (Becton
Dickinson) flow cytometer, and the data were analyzed with the CELL-
Quest Pro or FlowJo software.
CD4 T Cell Preparation and Differentiation
CD4+ cells were purified from single-cell suspensions of splenocytes
from chimeric mice with anti-mouse CD4 microbeads (Miltenyi Biotec,
Auburn, California). CD4+ T cells (1 3 106/ml) were stimulated with
5 mg/ml plate-bound anti-CD33 (145-2C11), 1 mg/ml anti-CD28 (37.51),
and 50 U of IL-2 (Roche, Indianapolis, Indiana) for 5–7 daysin
order to induce Th differentiation. For Th1 differentiation, 3.5 ng/ml
of IL-12 and 10 mg/ml of anti-IL-4 (11B11) were added. Th2 cultures
were supplemented with 10 ng/ml of IL-4 and 10 mg/ml of anti-IFN-g
(R4-6A2).
Cytokine Intracellular Staining
Freshly isolated splenocytes depleted of red blood cells or differenti-
ated Th1 and Th2 CD4+ T cells were stimulated with 50 ng/ml phorbol
myristyl acetate and 1.5 mM ionomycin (Calbiochem, San Diego, Cal-
ifornia) for 5 hr. Monensin (Sigma, St. Louis, Missouri) at 3 mM was
added during the last 3 hr of stimulation. Activated splenic cells were
first stained with flurochrome-conjugated anti-CD45.1, anti-CD45.2,
anti-CD4, and anti-NK1.1. Activated Th1 and Th2 cells were stained
with anti-CD45.1, anti-CD45.2 antibodies. Cells were then fixed in
2%–4% paraformaldehyde for 10 min at room temperature and
permeabilized with 0.2% saponin (Sigma), followed by staining with
anti-IL4 (11B11) and anti-IFN-g (XMG1.2) for flow cytometry.772 Immunity 27, 763–774, November 2007 ª2007 Elsevier Inc.Statistic Analysis
The two-tailed Student’s t test was used to analyze the statistic signif-
icance of the difference in percentage of T cells between different
groups. A p value smaller than 0.05 was considered statistically signif-
icant. * indicates p < 0.05, and ** indicates p < 0.01.
Supplemental Data
Three figures and three tables are available at http://www.immunity.
com/cgi/content/full/27/5/763/DC1/.
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